Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Ten HIV-positive cancer patients to receive donated cord blood with rare resistance gene.
Cancer today feels like AIDS in the mid-1990s.
Treatment with Opdivo appears to work well for HIV-positive people in small study.
HIV positive since 1996, Kevin Langeslay was diagnosed with stage 4 anal cancer in 2011.
Six out of nine patients experienced cancer remission with Opdivo or Keytruda.
Early and sustained antiretroviral treatment could help reduce the risk.
Its decline after the advent of antiretroviral therapy did not extend to Black men in the South.
We will never end the HIV and hepatitis epidemics by preventing people with preexisting conditions from accessing care.
HIV-positive people with low CD4 counts have poorer survival after a cancer diagnosis.
HIV/AIDS advocate Tim Horn highlights some golden rules for health activism.
Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials.
Cancer and HIV are invaders that the immune system fails to detect, and the similarities don’t end there.
Having either form of viral hepatitis was associated with about a 75 percent increased risk of non–Hodgkin lymphoma in a recent study.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.